Alpha Tau Medical (DRTSW) Non-Current Assets (2020 - 2026)
Alpha Tau Medical (DRTSW) posted Non-Current Assets of $27.4 million for Q1 2026, little changed sequentially from $27.4 million in Q4 2025, and up 13.6% YoY from $24.1 million in Q1 2025.
Alpha Tau Medical (DRTSW) Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Non-Current Assets for 7 years, with the latest figure at $27.4 million in Q1 2026.
- Quarterly Non-Current Assets rose 13.6% year-over-year to $27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.4 million (up 13.6% YoY) and the FY2025 annual result came in at $27.4 million, up 24.48% from the prior year.
- Non-Current Assets steadied at $27.4 million in Q1 2026 per DRTSW's latest filing, from $27.4 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $7.8 billion in Q1 2022 and troughed at $8.0 million in Q2 2022.
- A 5-year average of $479.4 million and a median of $21.2 million in 2024 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 90.46% in 2023, down 99.81% in 2023.
- Over 5 years, Non-Current Assets stood at $13.7 million in 2022, then soared by 58.22% to $21.6 million in 2023, then gained by 1.59% to $22.0 million in 2024, then increased by 24.48% to $27.4 million in 2025, then climbed by 0.26% to $27.4 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $27.4 million, $27.4 million, and $27.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - | 27.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.42 Mn |
| Mar 31, 2026 | 27.43 Mn |
| Dec 31, 2025 | 27.35 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Jun 30, 2025 | 25.18 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 21.98 Mn |
| Sep 30, 2024 | 20.94 Mn |
| Jun 30, 2024 | 20.80 Mn |
| Mar 31, 2024 | 21.24 Mn |
| Dec 31, 2023 | 21.63 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 13.67 Mn |
| Sep 30, 2022 | 8.04 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 7.84 Bn |
| Dec 31, 2021 | 9.57 Mn |
| Dec 31, 2020 | 5.53 Mn |